{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:54:36Z","timestamp":1791161676610,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2003,11,12]],"date-time":"2003-11-12T00:00:00Z","timestamp":1068595200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1038\/sj.npp.1300347","type":"journal-article","created":{"date-parts":[[2003,11,19]],"date-time":"2003-11-19T15:45:03Z","timestamp":1069256703000},"page":"694-704","source":"Crossref","is-referenced-by-count":70,"title":["Chronic Fluoxetine Treatment Partly Attenuates the Long-Term Anxiety and Depressive Symptoms Induced by MDMA (\u2018Ecstasy\u2019) in Rats"],"prefix":"10.1038","volume":"29","author":[{"given":"Murray R","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kong M","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly J","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clint G","family":"Gurtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn E","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L","family":"Cornish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain S","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,11,12]]},"reference":[{"key":"BF1300347_CR1","first-page":"911","volume":"242","author":"G Battaglia","year":"1987","unstructured":"Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB (1987). 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. J Pharm Exp Ther 242: 911\u2013916.","journal-title":"J Pharm Exp Ther"},{"key":"BF1300347_CR2","doi-asserted-by":"publisher","first-page":"10494","DOI":"10.1523\/JNEUROSCI.19-23-10494.1999","volume":"19","author":"S Benmansour","year":"1999","unstructured":"Benmansour S, Cecchi M, Morilak DA, Gerhardt GA, Javors MA, Gould GG et al (1999). Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J Neurosci 19: 10494\u201310501.","journal-title":"J Neurosci"},{"key":"BF1300347_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0306-4522(98)00742-8","volume":"92","author":"O Berton","year":"1999","unstructured":"Berton O, Durand M, Aguerre S, Mormede P, Chaouloff F (1999). Behavioral, neuroendocrine and serotonergic consequences of single social defeat and repeated fluoxetine pretreatment in the Lewis rat strain. Neuroscience 92: 327\u2013341.","journal-title":"Neuroscience"},{"key":"BF1300347_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/026988110201600112","volume":"16","author":"A Blokland","year":"2002","unstructured":"Blokland A, Lieben C, Deutz NEP (2002). Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat. J Psychopharmacol 16: 39\u201349.","journal-title":"J Psychopharmacol"},{"key":"BF1300347_CR5","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/S0140-6736(00)02276-5","volume":"355","author":"BP Boot","year":"2000","unstructured":"Boot BP, McGregor IS, Hall W (2000). MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks. Lancet 355: 1818\u20131821.","journal-title":"Lancet"},{"key":"BF1300347_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0028-3908(02)00407-0","volume":"44","author":"EJ Bull","year":"2003","unstructured":"Bull EJ, Hutson PH, Fone KC (2003). Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT(2C) receptor responsivity. Neuropharmacology 44: 439\u2013448.","journal-title":"Neuropharmacology"},{"key":"BF1300347_CR7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.2042-7158.1992.tb03592.x","volume":"44","author":"S Caccia","year":"1992","unstructured":"Caccia S, Bizzi A, Coltro G, Fracasso C, Frittoli E, Mennini T et al (1992a). Anorectic activity of fluoxetine and norfluoxetine in rats: relationship between brain concentrations and in-vitro potencies on monoaminergic mechanisms. J Pharm Pharmacol 44: 250\u2013254.","journal-title":"J Pharm Pharmacol"},{"key":"BF1300347_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/BF02244004","volume":"100","author":"S Caccia","year":"1990","unstructured":"Caccia S, Cappi M, Fracasso C, Garattini S (1990). Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat. Psychopharmacology 100: 509\u2013514.","journal-title":"Psychopharmacology"},{"key":"BF1300347_CR9","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0091-3057(96)00322-X","volume":"57","author":"S Caccia","year":"1997","unstructured":"Caccia S, Confalonieri S, Bergami A, Fracasso C, Anelli M, Garattini S (1997). Neuropharmacological effects of low and high doses of repeated oral dexfenfluramine in rats: a comparison with fluoxetine. Pharmacol Biochem Behav 57: 851\u2013856.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300347_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0028-3908(92)90066-X","volume":"31","author":"S Caccia","year":"1992","unstructured":"Caccia S, Fracasso C, Garattini S, Guiso G, Sarati S (1992b). Effects of short- and long-term administration of fluoxetine on the monoamine content of rat brain. Neuropharmacology 31: 343\u2013347.","journal-title":"Neuropharmacology"},{"key":"BF1300347_CR11","first-page":"464","volume":"15","author":"JC Cole","year":"2002","unstructured":"Cole JC, Sumnall HR, Grob C (2002). Sorted: ecstasy facts and fiction. Psychologist 15: 464\u2013467.","journal-title":"Psychologist"},{"key":"BF1300347_CR12","first-page":"338","volume":"241","author":"DL Commins","year":"1987","unstructured":"Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS (1987). Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharm Exp Ther 241: 338\u2013345.","journal-title":"J Pharm Exp Ther"},{"key":"BF1300347_CR13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0091-3057(99)00192-6","volume":"65","author":"TJ Connor","year":"2000","unstructured":"Connor TJ, Kelliher P, Shen Y, Harkin A, Kelly JP, Leonard BE (2000). Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test. Pharmacol Biochem Behav 65: 591\u2013597.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300347_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/026988110101500401","volume":"15","author":"CM Contreras","year":"2001","unstructured":"Contreras CM, Rodriguez-Landa JF, Gutierrez-Garcia AG, Bernal-Morales B (2001). The lowest effective dose of fluoxetine in the forced swim test significantly affects the firing rate of lateral septal nucleus neurones in the rat. J Psychopharmacol 15: 231\u2013236.","journal-title":"J Psychopharmacol"},{"key":"BF1300347_CR15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","volume":"23","author":"JF Cryan","year":"2002","unstructured":"Cryan JF, Markou A, Lucki I (2002). Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23: 238\u2013245.","journal-title":"Trends Pharmacol Sci"},{"key":"BF1300347_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1037\/1064-1297.5.2.107","volume":"5","author":"MJ Detke","year":"1997","unstructured":"Detke MJ, Johnson J, Lucki I (1997). Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp Clin Psychopharmacol 5: 107\u2013112.","journal-title":"Exp Clin Psychopharmacol"},{"key":"BF1300347_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0166-4328(96)00067-8","volume":"73","author":"MJ Detke","year":"1996","unstructured":"Detke MJ, Lucki I (1996). Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav Brain Res 73: 43\u201346.","journal-title":"Behav Brain Res"},{"key":"BF1300347_CR18","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0028-3908(99)00009-X","volume":"38","author":"M Durand","year":"1999","unstructured":"Durand M, Berton O, Aguerre S, Edno L, Combourieu I, Mormede P et al (1999). Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis axis in SHR and WKY rats. Neuropharmacology 38: 893\u2013907.","journal-title":"Neuropharmacology"},{"key":"BF1300347_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1476-5381.1978.tb07001.x","volume":"62","author":"SE File","year":"1978","unstructured":"File SE, Hyde JR (1978). Can social interaction be used to measure anxiety? Br J Pharmacol 62: 19\u201324.","journal-title":"Br J Pharmacol"},{"key":"BF1300347_CR20","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0091-3057(98)00208-1","volume":"62","author":"SE File","year":"1999","unstructured":"File SE, Ouagazzal AM, Gonzalez LE, Overstreet DH (1999). Chronic fluoxetine in tests of anxiety in rat lines selectively bred for differential 5-HT1A receptor function. Pharmacol Biochem Behav 62: 695\u2013701.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300347_CR21","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00213-001-0931-z","volume":"159","author":"KCF Fone","year":"2002","unstructured":"Fone KCF, Beckett SRG, Topham IA, Swettenham J, Ball M, Maddocks L (2002). Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity. Psychopharmacology 159: 437\u2013444.","journal-title":"Psychopharmacology"},{"key":"BF1300347_CR22","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S0893-133X(00)00130-5","volume":"23","author":"A Gamma","year":"2000","unstructured":"Gamma A, Buck A, Berthold T, Hell D, Vollenweider FX (2000). 3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by. Neuropsychopharmacol 23: 388\u2013395.","journal-title":"Neuropsychopharmacol"},{"key":"BF1300347_CR23","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.2042-7158.1976.tb04165.x","volume":"28","author":"AJ Goudie","year":"1976","unstructured":"Goudie AJ, Thornton EW, Wheeler TJ (1976). Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and on 5-hydroxytryptophan-induced anorexia. Evidence for serotoninergic inhibition of feeding. J Pharm Pharmacol 28: 318\u2013320.","journal-title":"J Pharm Pharmacol"},{"key":"BF1300347_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF02246288","volume":"119","author":"AR Green","year":"1995","unstructured":"Green AR, Cross AJ, Goodwin GM (1995). Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or \u2018Ecstasy\u2019). Psychopharmacology (Berl) 119: 247\u2013260.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1300347_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0031-9384(98)00298-4","volume":"67","author":"G Griebel","year":"1999","unstructured":"Griebel G, Cohen C, Perrault G, Sanger DJ (1999). Behavioral effects of acute and chronic fluoxetine in Wistar-Kyoto rats. Physiol Behav 67: 315\u2013320.","journal-title":"Physiol Behav"},{"key":"BF1300347_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0014-2999(02)01820-4","volume":"446","author":"CG Gurtman","year":"2002","unstructured":"Gurtman CG, Morley KC, Li KM, Hunt GE, McGregor IS (2002). Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonergic depletion. Eur J Pharmacol 446: 89\u201396.","journal-title":"Eur J Pharmacol"},{"key":"BF1300347_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0014-2999(87)90429-8","volume":"138","author":"PD Hrdina","year":"1987","unstructured":"Hrdina PD (1987). Regulation of high- and low-affinity [3H] imipramine recognition sites in rat brain by chronic treatment with antidepressants. Eur J Pharmacol 138: 159\u2013168.","journal-title":"Eur J Pharmacol"},{"key":"BF1300347_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/00008877-200211000-00002","volume":"13","author":"N Jones","year":"2002","unstructured":"Jones N, King SM, Duxon MS (2002). Further evidence for the predictive validity of the unstable elevated exposed plus-maze, a behavioural model of extreme anxiety in rats: differential effects of fluoxetine and chlordiazepoxide. Behav Pharmacol 13: 525\u2013535.","journal-title":"Behav Pharmacol"},{"key":"BF1300347_CR29","first-page":"855","volume":"276","author":"R Lew","year":"1996","unstructured":"Lew R, Sabol KE, Chou C, Vosmer GL, Richards J, Seiden LS (1996). Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: radioligand binding and autoradiography studies. J Pharm Exp Ther 276: 855\u2013865.","journal-title":"J Pharm Exp Ther"},{"key":"BF1300347_CR30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0091-3057(94)90422-7","volume":"49","author":"S Lightowler","year":"1994","unstructured":"Lightowler S, Kennett GA, Williamson IJ, Blackburn TP, Tulloch IF (1994). Anxiolytic-like effect of paroxetine in a rat social interaction test. Pharmacol Biochem Behav 49: 281\u2013285.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300347_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/026988110101500310","volume":"15","author":"N MacInnes","year":"2001","unstructured":"MacInnes N, Handley SL, Harding GF (2001). Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms. J Psychopharmacol 15: 181\u2013186.","journal-title":"J Psychopharmacol"},{"key":"BF1300347_CR32","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1523\/JNEUROSCI.18-13-05086.1998","volume":"18","author":"JE Malberg","year":"1998","unstructured":"Malberg JE, Seiden LS (1998). Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J Neurosci 18: 5086\u20135094.","journal-title":"J Neurosci"},{"key":"BF1300347_CR33","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/sj.npp.1300185","volume":"28","author":"IS McGregor","year":"2003","unstructured":"McGregor IS, Clemens KC, Van der Plasse G, Hunt GE, Chen F, Lawrence AJ (2003a). Increased anxiety three months after brief MDMA (\u2018Ecstasy\u2019) treatment in rats: association with altered 5-HT receptor and transporter density. Neuropsychopharmacology 28: 1472\u20131484.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300347_CR34","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00213-003-1452-8","volume":"168","author":"IS McGregor","year":"2003","unstructured":"McGregor IS, Gurtman CG, Morley KC, Clemens KJ, Blokland A, Li KM et al (2003b). Increased anxiety and \u201cdepressive\u201d symptoms months after MDMA (\u2018Ecstasy\u2019) in rats: drug-induced hyperthermia does not predict long-term outcomes. Psychopharmacology 168: 465\u2013474.","journal-title":"Psychopharmacology"},{"key":"BF1300347_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0378-4274(99)00219-2","volume":"112\u2013113","author":"P McGuire","year":"2000","unstructured":"McGuire P (2000). Long term psychiatric and cognitive effects of MDMA use. Toxicol Lett 112\u2013113: 153\u2013156.","journal-title":"Toxicol Lett"},{"key":"BF1300347_CR36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1037\/0097-7403.20.4.402","volume":"20","author":"TR Minor","year":"1994","unstructured":"Minor TR, Dess NK, Ben-David E, Chang WC (1994). Individual differences in vulnerability to inescapable shock in rats. J Exp Psychol Anim Behav Process 20: 402\u2013412.","journal-title":"J Exp Psychol Anim Behav Process"},{"key":"BF1300347_CR37","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s002130000545","volume":"152","author":"MJ Morgan","year":"2000","unstructured":"Morgan MJ (2000). Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology 152: 230\u2013248.","journal-title":"Psychopharmacology"},{"key":"BF1300347_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0014-2999(01)01512-6","volume":"433","author":"KC Morley","year":"2001","unstructured":"Morley KC, Gallate JE, Hunt GE, Mallet PE, McGregor IS (2001). Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine (\u2018ecstasy\u2019). Eur J Pharmacol 433: 91\u201399.","journal-title":"Eur J Pharmacol"},{"key":"BF1300347_CR39","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1046\/j.1471-4159.1996.67062434.x","volume":"67","author":"D Muck-Seler","year":"1996","unstructured":"Muck-Seler D, Jevric-Causevic A, Diksic M (1996). Influence of fluoxetine on regional serotonin synthesis in the rat brain. J Neurochem 67: 2434\u20132442.","journal-title":"J Neurochem"},{"key":"BF1300347_CR40","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0028-3908(98)00029-X","volume":"37","author":"E O'Shea","year":"1998","unstructured":"O'Shea E, Granados R, Esteban B, Colado MI, Green AR (1998). The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (ecstasy). Neuropharmacology 37: 919\u2013926.","journal-title":"Neuropharmacology"},{"key":"BF1300347_CR41","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s002130051156","volume":"147","author":"ME Page","year":"1999","unstructured":"Page ME, Detke MJ, Dalvi A, Kirby LG, Lucki I (1999). Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology (Berl) 147: 162\u2013167.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1300347_CR42","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/S0278-5846(01)00204-4","volume":"25","author":"WP Pare","year":"2001","unstructured":"Pare WP, Tejani-Butt S, Kluczynski J (2001). The emergence test: effects of psychotropic drugs on neophobic disposition in Wistar Kyoto (WKY) and Sprague Dawley rats. Prog Neuropsychopharmacol Biol Psychiatry 25: 1615\u20131628.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BF1300347_CR43","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/hup.351","volume":"16","author":"AC Parrott","year":"2001","unstructured":"Parrott AC (2001). Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research. Hum Psychopharmacol 16: 557\u2013577.","journal-title":"Hum Psychopharmacol"},{"key":"BF1300347_CR44","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/hup.415","volume":"17","author":"AC Parrott","year":"2002","unstructured":"Parrott AC, Buchanan T, Scholey AB, Heffernan T, Ling J, Rodgers J (2002). Ecstasy\/MDMA attributed problems reported by novice, moderate and heavy recreational users. Hum Psychopharmacol 17: 309\u2013312.","journal-title":"Hum Psychopharmacol"},{"key":"BF1300347_CR45","first-page":"105","volume":"60","author":"AC Parrott","year":"2000","unstructured":"Parrott AC, Sisk E, Turner JJD (2000). Psychobiological problems in heavy \u2018ecstasy\u2019 (MDMA) polydrug users. Drug Alcohol Depend 60: 105\u2013110.","journal-title":"Drug Alcohol Depend"},{"key":"BF1300347_CR46","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","volume":"47","author":"RD Porsolt","year":"1978","unstructured":"Porsolt RD, Anton G, Blavet N, Jalfre M (1978). Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47: 379\u2013391.","journal-title":"Eur J Pharmacol"},{"key":"BF1300347_CR47","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0031-9384(95)02234-1","volume":"60","author":"MA Prendergast","year":"1996","unstructured":"Prendergast MA, Hendricks SE, Yells DP, Balogh S (1996). Conditioned taste aversion induced by fluoxetine. Physiol Behav 60: 311\u2013315.","journal-title":"Physiol Behav"},{"key":"BF1300347_CR48","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0378-4274(99)00216-7","volume":"112","author":"GA Ricaurte","year":"2000","unstructured":"Ricaurte GA, McCann UD, Szabo Z, Scheffel U (2000). Toxicodynamics and long-term toxicity of the recreational drug, 3,4-methylenedioxymethamphetamine (MDMA, \u2018Ecstasy\u2019). Toxicol Lett 112: 143\u2013146.","journal-title":"Toxicol Lett"},{"key":"BF1300347_CR49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0376-8716(98)00051-9","volume":"52","author":"F Schifano","year":"1998","unstructured":"Schifano F, Di Furia L, Forza G, Minicuci N, Bricolo R (1998). MDMA (\u2018ecstasy\u2019) consumption in the context of polydrug abuse: a report on 150 patients. Drug Alcohol Depend 52: 85\u201390.","journal-title":"Drug Alcohol Depend"},{"key":"BF1300347_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0091-3057(99)00193-8","volume":"65","author":"RC Silva","year":"2000","unstructured":"Silva RC, Brandao ML (2000). Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis. Pharmacol Biochem Behav 65: 209\u2013216.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300347_CR51","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/0091-3057(78)90221-6","volume":"9","author":"JM Stein","year":"1978","unstructured":"Stein JM, Wayner MJ, Kantak KM, Adler-Stein RL (1978). Synergistic action of p-chloroamphetamine and fluoxetine on food and water consumption patterns in the rat. Pharmacol Biochem Behav 9: 677\u2013685.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300347_CR52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0278-5846(02)00308-1","volume":"27","author":"S Tejani-Butt","year":"2003","unstructured":"Tejani-Butt S, Kluczynski J, Pare WP (2003). Strain-dependent modification of behavior following antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry 27: 7\u201314.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BF1300347_CR53","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/00001756-199902250-00020","volume":"10","author":"CT To","year":"1999","unstructured":"To CT, Anheuer ZE, Bagdy G (1999). Effects of acute and chronic fluoxetine treatment of CRH-induced anxiety. Neuroreport 10: 553\u2013555.","journal-title":"Neuroreport"},{"key":"BF1300347_CR54","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0376-8716(99)00002-2","volume":"55","author":"L Topp","year":"1999","unstructured":"Topp L, Hando J, Dillon P, Roche A, Solowij N (1999). Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend 55: 105\u2013115.","journal-title":"Drug Alcohol Depend"},{"key":"BF1300347_CR55","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0278-5846(02)00338-X","volume":"27","author":"M Vaswani","year":"2003","unstructured":"Vaswani M, Linda FK, Ramesh S (2003). Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry 27: 85\u2013102.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BF1300347_CR56","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s002130000563","volume":"153","author":"RJ Verkes","year":"2001","unstructured":"Verkes RJ, Gijsman HJ, Pieters MSM, Schoemaker RC, de Visser S, Kuijpers M et al (2001). Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology 153: 196\u2013202.","journal-title":"Psychopharmacology"},{"key":"BF1300347_CR57","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1348\/000712600161772","volume":"91","author":"M Wareing","year":"2000","unstructured":"Wareing M, Fisk JE, Murphy PN (2000). Working memory deficits in current and previous users of MDMA (\u2018Ecstasy\u2019). Br J Psychol 91: 181\u2013188.","journal-title":"Br J Psychol"},{"key":"BF1300347_CR58","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0024-3205(95)00209-O","volume":"57","author":"DT Wong","year":"1995","unstructured":"Wong DT, Bymaster FP, Engleman EA (1995). Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci 57: 411\u2013441.","journal-title":"Life Sci"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1300347.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300347","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300347.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:45:23Z","timestamp":1684219523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1300347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11,12]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["BF1300347"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1300347","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11,12]]}}}